Jukka Peltola,Albert Colon,José Pimentel,Volker A. Coenen,António Gil‐Nagel,A Gonçalves-Ferreira,Kai Lehtimäki,Philippe Ryvlin,Rod S Taylor,Linda Ackermans,Jacqueline Ardesch,Carla Bentes,Magdalena Bosak,Jorge G. Burneo,Clara Chamadoira,Christian E. Elger,Lóránd Erőss,Dániel Fabó,Howard J. Faulkner,Jacek Gawłowicz
The efficacy of deep brain stimulation of the anterior nucleus of the thalamus (ANT DBS) in patients with drug-resistant epilepsy (DRE) was demonstrated in the double-blind Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy randomized controlled trial. The Medtronic Registry for Epilepsy (MORE) aims to understand the safety and longer-term effectiveness of ANT DBS therapy in routine clinical practice.